Biological Activity of Lenalidomide and Its Underlying Therapeutic Effects in Multiple Myeloma

Ria, R., Reale, A., Solimando, A. G., Mangialardi, G., Moschetta, M., Gelao, L., Iodice, G., & Vacca, A. (2012). Induction Therapy and Stem Cell Mobilization in Patients with Newly Diagnosed Multiple Myeloma. Stem Cells International, 2012(), 720-725. https://doi.org/10.1155/2012/607260
Cortelezzi, A., Sciume, M., & Reda, G. (2012). Lenalidomide in the Treatment of Chronic Lymphocytic Leukemia. Advances in Hematology, 2012(), 186-192. https://doi.org/10.1155/2012/393864
林毓棼（2012）。Study on the Roles of Hypoxia-related Adrenomedullin (AM) in Acute Myeloid Leukemia (AML)〔碩士論文，國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU.2012.00090
Cheung, W. C. (2006). The molecular mechanisms of arsenic trioxide in multiple myeloma [doctoral dissertation, The University of Hong Kong]. Airiti Library. https://www.airitilibrary.com/Article/Detail?DocID=U0029-1812201200014057
Alegre, A., icuña, I., & Aguado, B. (2012). Safety and Efficacy of Lenalidomide in Relapsed or Refractory Multiple Myeloma. Clinical Medicine Insights: Oncology, (), 1-10. https://doi.org/10.4137/CMO.S7275